Project Grant R01HG011736
- This Project Grant award from the National Institutes of Health's National Human Genome Research Institute provided $768,678 to Molecular Assemblies, Inc. to develop a fully enzymatic oligonucleotide synthesis cycle using engineered template-independent polymerases and a novel phosphate dNTP blocking group. The award supports the goals of the Human Genome Research program (CFDA 93.172) to accelerate genome research and its application to human health. Specifically, the awardee will engineer...
- Triton Systems, Inc. received a $249,712 Project Grant award from the Department of Energy Office of Science on February 22, 2021 to develop a fast, scalable, automated, one-pot process for assembly of DNA oligonucleotides into large gene sequences. The work will be performed in Chelmsford, Massachusetts through February 21, 2022. The award is being made under the Office of Science Financial Assistance Program (CFDA #81.049), which supports basic research to deliver scientific discoveries and...
- Electronic Biosciences, Inc. received a $350,000 Project Grant award from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859) on June 5, 2025, with an expected completion date of May 31, 2027. The award supports the development and optimization of a novel enzyme-based, single-molecule protein sequencing system designed to address critical limitations in current proteomics technologies. The company will develop an innovative...
- This Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) is providing $275,000 to Dinya DNA Inc. to support the commercial development of a novel DNA synthesis technology. The key products or services being delivered include: Developing new methods to ensure higher fidelity DNA precursors, which are the building blocks for DNA synthesis Reducing synthesis costs by streamlining the DNA synthesis reactions...
- This $256,000 National Science Foundation Engineering grant supports the development of an easy RNA adenylation method for deep sequencing of picogram RNA samples with high resolution. Specifically, Ezrabio Inc. will develop a versatile and cost-effective library construction technology that enables protein translation monitoring on a variety of biological samples. The proposed technology relies on a novel enzyme system capable of 5' adenylation and 3' polyadenylation of RNA fragments to...
- Micropure Genomics Inc. received a $274,199 Project Grant award from the National Science Foundation to advance methods for rapid, end-to-end sample preparation for sequencing applications. Under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084), the company will develop an automated process relying on electro-hydrodynamic trapping to isolate genomic material like DNA or RNA from cells in a flow cartridge. The process aims to significantly reduce preparation time while...
- This $3,000,000 project grant, awarded by the National Science Foundation (NSF) under the Engineering (CFDA 47.041) program, aims to solve the long-standing challenge of developing self-amplifying ribonucleic acid (SARNA) technologies. The project, led by Trustees of Boston University, a private non-profit research university, will: Synthesize a diverse library of modified nucleoside triphosphates (ModNTPs) and use them to produce modified SARNA with extended cellular half-life. Evaluate the...
- Federal Grant Award Summary Electronic Biosciences, Inc. received a $383,482 Phase I Small Business Innovation Research (SBIR) Project Grant from the National Human Genome Research Institute (NHGRI) under the Human Genome Research program (CFDA 93.172), awarded June 6, 2025, with a completion date of May 31, 2027. The project focuses on developing SPINSEQ, an innovative RNA sequencing platform designed to deliver highly precise and accurate transcriptomic analysis while preserving RNA...
- This National Science Foundation (NSF) Project Grant award for $380,074, awarded on September 1, 2024, aims to develop a platform for instrument-free, easy-to-interpret quantitative analysis of molecular biomarkers. The project will produce a general methodology adaptable to a range of molecular targets, including potential new agents. The key products to be delivered include: A "yes/no" output for quantitative measurement, enabled through stoichiometry and negative cooperativity-based...
- The federal Project Grant award of $283,805 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports the development of a novel cell-free, high-throughput platform to expedite the engineering of enzymes for biocatalytic "BioClick" reactions. The project, undertaken by Invizyne Technologies, Inc., a small disadvantaged business in Monrovia, CA, focuses on establishing an efficient cell-free protein...
A LOW-COST BENCHTOP OLIGONUCLEOTIDE SYNTHESIZER USING INKJET ENZYMATIC DNA SYNTHESIS - ABSTRACT THE OBJECTIVE OF THIS PROPOSAL IS TO DEVELOP A BENCHTOP, INKJET-BASED, OLIGONUCLEOTIDE SYNTHESIZER USING AQUEOUS, ENZYMATIC DNA SYNTHESIS TECHNOLOGIES FOR THE PARALLEL SYNTHESIS OF UP TO 1 MILLION HIGH-QUALITY OLIGONUCLEOTIDES PER DAY. THE SYSTEM WILL DELIVER >10-FOLD IMPROVEMENTS IN THE KEY METRICS OF COST, QUALITY, AND THROUGHPUT COMPARED TO EXISTING TECHNOLOGIES. THE SYNTHESIS BIOCHEMISTRY WILL UTILIZE ENGINEERED TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE ENZYMES THAT HAVE BEEN OPTIMIZED FOR INCORPORATION OF 3' AMINOXY REVERSIBLE TERMINATOR NUCLEOTIDES. THIS APPROACH HAS SEVERAL ADVANTAGES, INCLUDING PROVEN PERFORMANCE IN THE SYNTHESIS OF OLIGONUCLEOTIDES UP TO 300 NUCLEOTIDES ON MICROBEADS. HERE, WE WILL ADAPT THE TECHNOLOGY TO ENABLE DNA SYNTHESIS ON FUNCTIONALIZED MICROSCOPE SLIDES USING INKJETS FOR PRECISE REAGENT DELIVERY. A MULTIDISCIPLINARY APPROACH WILL BE FOLLOWED TO ADVANCE TOWARD THE GOALS IN TERMS OF ENGINEERING FOR INSTRUMENTATION DEVELOPMENT, BIOCHEMISTRY AND PROTOCOL OPTIMIZATION, AND PERFORMANCE BENCHMARKING OF THE SYNTHESIZED OLIGONUCLEOTIDES. DURING THE FIRST YEAR, WE WILL BUILD AN INITIAL TESTBED TO ENABLE VERIFICATION AND OPTIMIZATION OF INDIVIDUAL COMPONENTS, MATERIALS, REAGENTS, AND PROTOCOLS. IN THE SECOND YEAR, WE WILL BUILD A FULLY AUTOMATED PROTOTYPE INSTRUMENT, AND REFINE THE PROTOCOLS AND SOFTWARE TO ALLOW SYNTHESIS OF LONG OLIGONUCLEOTIDES. FINALLY, YEAR-3, WE WILL BUILD MULTIPLE BENCHTOP INSTRUMENTS AND WORK WITH PARTNER LABORATORIES TO TEST THE OLIGONUCLEOTIDES IN SEVERAL 'REAL WORLD' APPLICATIONS. SUBSEQUENT COMMERCIALIZATION OF THE INSTRUMENTS WILL DEMOCRATIZE ACCESS TO RAPID HIGH-DENSITY OLIGONUCLEOTIDE SYNTHESIS, AND REVOLUTIONIZE APPROACHES TO A WIDE VARIETY OF SYNTHETIC BIOLOGY AND FUNCTIONAL GENOMICS APPLICATIONS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | ($1) | 12/4/24 | ||
| Not listed | $0 | 10/31/24 | ||
| Not listed | $0 | 10/31/24 | ||
| Not listed | $0 | 8/6/24 | ||
| Not listed | $0 | 8/6/24 |